((自动化翻译由路透提供，请见免责声明 ))
11月8日 - ** 医疗保健服务提供商 Evolent Health 股价下跌 41.21% 至 14.45 美元
** 该公司将 (link) 的年收入预期从之前的 25.6 亿美元至 26.0 亿美元下调至 25.5 亿美元至 25.8 亿美元。
** 预计年度调整后核心利润介于 1.6 亿美元至 1.75 亿美元之间，而之前的预期为 2.3 亿美元至 2.45 亿美元。
** 第三季度实现营业收入 6.214 亿美元，低于预期的 6.2715 亿美元 -LSEG
** 第三季度核心利润为 3180 万美元，低于预期的 6270 万美元，受到医疗费用增加的影响。
** 今年以来股价下跌约 56
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.